Most lately, it's been recognized that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar regions as classical opioid receptors, it binds to the big range of endogenous opioids. As opposed to most opioid receptors, this receptor acts as a scavenger https://josefah864dvr4.bloggazza.com/profile